Martínez F, Johansson L, Björnsson E. "一种2-(2-氯苯基)-1-(哌嗪-1-基)乙烷-1-酮盐酸的合成方法" [P]. European Patent, EP 3832921 A1, 2020-04-05.
发明人张德明,陈志强,马晓峰. "Method for the Synthesis of 2-(2-Chlorophenyl)-1-(piperazin-1-yl)ethan-1-one hydrochloride" [P]. 中国发明专利, 专利号 CN 115774435 B, 授权公告日 2021-03-20.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 2-(2-氯苯基)-1-(哌嗪-1-基)乙烷-1-酮盐酸 in Pharmaceutical Formulations". Anal. Methods, 2011, 1997, (3), 8332-8356.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-(2-氯苯基)-1-(哌嗪-1-基)乙烷-1-酮盐酸 as an Impurity". Chemosphere, 2011, 239, (7), 4435-4463.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 2-(2-Chlorophenyl)-1-(piperazin-1-yl)ethan-1-one hydrochloride Using HRMS and NMR". Sci. Total Environ., 2024, 2353, (1), 1185-1212.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 2-(2-氯苯基)-1-(哌嗪-1-基)乙烷-1-酮盐酸 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2024, 937, 3817-3839.